Sage Journals: Discover world-class research

Abstract

Background:

US studies suggest a positive association between attention deficit–hyperactivity disorder (ADHD) and the risk of exposure to prescription opioids. However, whether this association holds in Asian countries remains unclear.

Methods:

In total, 91,518 children and adolescents with ADHD and 91,518 age- and sex-matched controls were enrolled for the period of 2001 to 2009; they were followed up until the end of 2011 to determine whether they had used prescription opioids.

Results:

Children (hazard ratio [HR]: 5.83) and adolescents (HR: 3.44) with ADHD had a higher likelihood of receiving opioid prescriptions than did their matched controls. Furthermore, patients with ADHD had greater likelihoods of cumulative exposure to opioids of >14 (HR: 5.93) and >30 days (HR: 6.07).

Discussion:

Owing to the evidence of a significant link between opioid prescription use and eventual abuse, close monitoring for prescription opioid use is necessary for at-risk children and adolescents with ADHD.

Keywords

attention deficit–hyperactivity disorder prescription opioids medical conditions mental disorders

Get full access to this article

View all access options for this article.

References

Brown

K. W.

Carlisle

Raman

S. R.

Shrader

Jiao

Smith

M. J.

Einhorn

L. M.

Wong

C. A.

(2020). Children and the opioid epidemic: Age-stratified exposures and harms. Health Affairs, 39(10), 1737–1742.

Charlson

M. E.

Pompei

Ales

K. L.

MacKenzie

C. R.

(1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. International Journal of Chronic Diseases, 40(5), 373–383.

Chen

M. H.

Hsu

J. W.

Huang

K. L.

Bai

Y. M.

N. Y.

T. P.

C. T.

Lin

W. C.

Tsai

S. J.

Pan

T. L.

Chang

W. H.

Chen

T. J.

(2018). Sexually transmitted infection among adolescents and young adults with attention-deficit/hyperactivity disorder: A nationwide longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry, 57(1), 48–53.

Chen

M. H.

Hsu

J. W.

Huang

K. L.

T. P.

C. T.

Lin

W. C.

Tsai

S. J.

Cheng

C. M.

Chang

W. H.

Pan

T. L.

Chen

T. J.

Bai

Y. M.

(2019). Risk and coaggregation of major psychiatric disorders among first-degree relatives of patients with bipolar disorder: A nationwide population-based study. Psychological Medicine, 49, 2397–2404.

Chen

M. H.

Lan

W. H.

Hsu

J. W.

Huang

K. L.

T. P.

C. T.

Lin

W. C.

Tsai

C. F.

Tsai

S. J.

Lee

Y. C.

Chen

Y. S.

Pan

T. L.

Chang

W. H.

Chen

T. J.

Bai

Y. M.

(2016). Risk of developing type 2 diabetes in adolescents and young adults with autism spectrum disorder: A nationwide longitudinal study. Diabetes Care, 39(5), 788–793.

Cicero

T. J.

Ellis

M. S.

Surratt

H. L.

Kurtz

S. P.

(2014). The changing face of heroin use in the United States: A retrospective analysis of the past 50 years. JAMA Psychiatry, 71(7), 821–826.

Coussens

N. P.

Sittampalam

G. S.

Jonson

S. G.

Hall

M. D.

Gorby

H. E.

Tamiz

A. P.

McManus

O. B.

Felder

C. C.

Rasmussen

(2019). The opioid crisis and the future of addiction and pain therapeutics. Journal of Pharmacology and Experimental Therapeutics, 371(2), 396–408.

Griesler

P. C.

M. C.

Wall

M. M.

Kandel

D. B.

(2021). Assessment of prescription opioid medical use and misuse among parents and their adolescent offspring in the US. JAMA Network Open, 4(1), e2031073.

Kang

K. H.

Kuo

L. F.

Cheng

I. C.

Chang

C. S.

Tsay

W. I.

(2017). Trends in major opioid analgesic consumption in Taiwan, 2002-2014. Journal of the Formosan Medical Association = Taiwan yi zhi, 116(7), 529–535.

10.

Liu

C. Y.

Hung

Y. T.

Chuang

Y. L.

Chen

Y. J.

Weng

W. S.

Liu

J. S.

(2006). Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. Journal of Health Management, 4, 1–22.

11.

Olsson

M. O.

Ojehagen

Bradvik

Kronstrand

Hakansson

(2017). High rates of tramadol use among treatment-seeking adolescents in Malmo, Sweden: A study of hair analysis of nonmedical prescription opioid use. Journal of Addiction Medicine, 2017, 6716929.

12.

Pan

H. H.

S. T.

C. C.

Wang

J. O.

Lin

T. C.

Wang

K. Y.

(2013). Trends in the consumption of opioid analgesics in Taiwan from 2002 to 2007: A population-based study. Journal of Pain and Symptom Management, 45, 272–278.

13.

Quinn

P. D.

Chang

Hur

Gibbons

R. D.

Lahey

B. B.

Rickert

M. E.

Sjölander

Lichtenstein

Larsson

D’Onofrio

B. M.

(2017). ADHD medication and substance-related problems. The American Journal of Psychiatry, 174(9), 877–885.

14.

Quinn

P. D.

Fine

K. L.

Rickert

M. E.

Sujan

A. C.

Boersma

Chang

Franck

Lichtenstein

Larsson

D’Onofrio

B. M.

(2020). Association of Opioid prescription initiation during adolescence and young adulthood with subsequent substance-related morbidity. JAMA Pediatrics, 174(11), 1048–1055.

15.

Quinn

P. D.

Hur

Chang

Krebs

E. E.

Bair

M. J.

Scott

E. L.

Rickert

M. E.

Gibbons

R. D.

Kroenke

D’Onofrio

B. M.

(2017). Incident and long-term opioid therapy among patients with psychiatric conditions and medications: A national study of commercial health care claims. Pain, 158(1), 140–148.

16.

Quinn

P. D.

Hur

Chang

Scott

E. L.

Krebs

E. E.

Bair

M. J.

Rickert

M. E.

Gibbons

R. D.

Kroenke

D’Onofrio

B. M.

(2018). Association of mental health conditions and treatments with long-term opioid analgesic receipt among adolescents. JAMA Pediatrics, 172(5), 423–430.

17.

Quinn

P. D.

Rickert

M. E.

Franck

Sariaslan

Boersma

Lichtenstein

Larsson

D’Onofrio

B. M.

(2019). Associations of mental health and family background with opioid analgesic therapy: A nationwide Swedish register-based study. Pain, 160(11), 2464–2472.

18.

Shanahan

Hill

S. N.

Bechtiger

Steinhoff

Godwin

Gaydosh

L. M.

Harris

K. M.

Dodge

K. A.

Copeland

W. E.

(2021). Prevalence and childhood precursors of opioid use in the early decades of life. JAMA Pediatrics, 175(3), 276–285.

19.

Stoicea

Costa

Periel

Uribe

Weaver

Bergese

S. D.

(2019). Current perspectives on the opioid crisis in the US healthcare system: A comprehensive literature review. Medicine (Baltimore), 98(20), e15425.

20.

Vowles

K. E.

McEntee

M. L.

Julnes

P. S.

Frohe

Ney

J. P.

van der Goes

D. N.

(2015). Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain, 156(4), 569–576.

21.

Wei

Y. J.

Zhu

Liu

Bussing

Winterstein

A. G.

(2018). Prevalence of and factors associated with long-term concurrent use of stimulants and opioids among adults with attention-deficit/hyperactivity disorder. JAMA Network Open, 1(4), e181152.

22.

Wickens

C. M.

Kao

Ialomiteanu

A. R.

Dubrovskaya

Kenney

Vingilis

Erickson

Kolla

N. J.

Stoduto

Soule

Mann

R. E.

(2020). Conduct disorder and attention-deficit/hyperactivity disorder as risk factors for prescription opioid use. Drug and Alcohol Dependence, 213, 108103.

23.

Zhang

Wang

H. E.

Bai

Y. M.

Tsai

S. J.

T. P.

Chen

T. J.

Wang

Y. P.

Chen

M. H.

(2021). Inflammatory bowel disease is associated with higher dementia risk: A nationwide longitudinal study. Gut, 70(1), 85–91.

24.

Zou

(2004). A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology, 159(7), 702–706.

Risk of Prescription Opioid Exposure in Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Nationwide Longitudinal Study

Abstract

Background:

Methods:

Results:

Discussion:

Keywords

Get full access to this article

References